Faro: Valuation, Funding & Investors
Faro is a San Diego-based software company that provides structured data and AI infrastructure for clinical development. The company's platform translates complex scientific, medical, and operational concepts into machine-readable intent and is used by major pharmaceutical companies to design clinical studies, identify risks, and automate development lifecycles.
Leadership & Board
Latest Estimated Valuation
- Total Amount Raised
- $37M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $37M
- Latest Funding Round
- Series B
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 27, 2026 | Series B | $37.30M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Merck Global Health Innovation Fund | Series B |
| S32 | Series B |
| General Catalyst | Series B |
| Northpond Ventures | Series B |
| Polaris Partners | Series B |
| PTX Capital | Series B |
| Zetta | Series B |
| Ankona Capital | Series B |
Similar Companies
A snapshot of private companies similar to Faro, helping you discover and navigate related company profiles.
Related News and Analysis









